• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环氧化酶-2在慢性硬膜下血肿形成中的可能作用。

Possible role of cyclooxygenase-2 in developing chronic subdural hematoma.

作者信息

Hara Mutsuya, Tamaki Masashi, Aoyagi Masaru, Ohno Kikuo

机构信息

Department of Neurosurgery, School of Medicine, Tokyo Medical and Dental University, Japan.

出版信息

J Med Dent Sci. 2009 Sep;56(3):101-6.

PMID:20099472
Abstract

Inflammatory cytokines are reportedly involved in the pathogenesis of chronic subdural hematomas (CSH), and the angiogenesis of hematomas has particularly been in focus. Cyclooxygenase-2 (COX-2) is an essential enzyme for the synthesis of prostaglandin E2 (PGE2). The COX-2-PGE2 pathway has been shown to influence angiogenic factors such as vascular endothelial growth factor (VEGF). We investigated the association of COX-2 expression in the dura mater and outer membrane with the pathogenesis of CSH, and suggested a treatment strategy on the basis of this association. Hematoma fluid and serum samples obtained from 37 patients, and samples of the dura mater and outer CSH membrane obtained from 13 patients during the operation were examined in this study. The concentrations of PGE2 in relation to COX-2 in the hematoma fluid were significantly higher than those in the serum. Immunohistochemical analyses revealed COX-2-positive cells in the outer membrane of CSHs. There was a linear and significant relationship between PGE2 concentration in hematoma fluid and the interval from trauma to initial surgery. COX-2 may play a crucial role during the development of CSHs. Our study might lead to the development of anti-COX-2 treatment options that aim to minimize repeat surgery and choose medical therapy by reducing CSH morbidity and recurrence rate in patients with CSH.

摘要

据报道,炎性细胞因子参与慢性硬膜下血肿(CSH)的发病机制,血肿的血管生成尤其受到关注。环氧化酶-2(COX-2)是前列腺素E2(PGE2)合成所必需的酶。COX-2-PGE2途径已被证明会影响血管内皮生长因子(VEGF)等血管生成因子。我们研究了硬脑膜和外膜中COX-2表达与CSH发病机制的关系,并基于这种关系提出了一种治疗策略。本研究检测了37例患者的血肿液和血清样本,以及13例患者手术中获取的硬脑膜和CSH外膜样本。血肿液中与COX-2相关的PGE2浓度显著高于血清中的浓度。免疫组化分析显示CSH外膜中有COX-2阳性细胞。血肿液中PGE2浓度与外伤至初次手术的间隔时间呈线性显著关系。COX-2可能在CSH的发展过程中起关键作用。我们的研究可能会促成抗COX-2治疗方案的开发,旨在通过降低CSH患者的发病率和复发率,尽量减少再次手术并选择药物治疗。

相似文献

1
Possible role of cyclooxygenase-2 in developing chronic subdural hematoma.环氧化酶-2在慢性硬膜下血肿形成中的可能作用。
J Med Dent Sci. 2009 Sep;56(3):101-6.
2
Vascular endothelial growth factor in chronic subdural haematomas.慢性硬膜下血肿中的血管内皮生长因子
J Clin Neurosci. 2001 Sep;8(5):411-5. doi: 10.1054/jocn.2000.0951.
3
Cyclooxygenase-2 increases hypoxia-inducible factor-1 and vascular endothelial growth factor to promote angiogenesis in gastric carcinoma.环氧化酶-2通过增加缺氧诱导因子-1和血管内皮生长因子来促进胃癌血管生成。
J Biomed Sci. 2005;12(1):229-41. doi: 10.1007/s11373-004-8177-5.
4
Angiotensin converting enzyme inhibition for arterial hypertension reduces the risk of recurrence in patients with chronic subdural hematoma possibly by an antiangiogenic mechanism.血管紧张素转换酶抑制剂治疗动脉高血压可降低慢性硬膜下血肿患者的复发风险,其机制可能是通过抗血管生成。
Neurosurgery. 2007 Oct;61(4):788-92; discussion 792-3. doi: 10.1227/01.NEU.0000298907.56012.E8.
5
[Histological study of operated cases of chronic subdural hematoma in adults: relationship between dura mater and outer membrane].成人慢性硬膜下血肿手术病例的组织学研究:硬脑膜与外膜的关系
No Shinkei Geka. 1997 Aug;25(8):701-5.
6
The role of cyclooxygenase-2 in mediating the effects of histamine on cell proliferation and vascular endothelial growth factor production in colorectal cancer.环氧化酶-2在介导组胺对结直肠癌细胞增殖及血管内皮生长因子产生的影响中的作用
Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):6807-15. doi: 10.1158/1078-0432.CCR-05-0675.
7
Prolonged drainage reduces the recurrence of chronic subdural hematoma.长期引流可降低慢性硬膜下血肿的复发率。
Br J Neurosurg. 2009 Dec;23(6):606-11. doi: 10.3109/02688690903386983.
8
Expression of the TGF-β-ALK-1 pathway in dura and the outer membrane of chronic subdural hematomas.转化生长因子-β-激活素受体样激酶-1通路在慢性硬膜下血肿硬脑膜及外膜中的表达
Neurol Med Chir (Tokyo). 2014;54(5):357-62. doi: 10.2176/nmc.oa2013-0019. Epub 2013 Dec 5.
9
Subdural hematoma (SDH): assessment of macrophage reactivity within the dura mater and underlying hematoma.硬膜下血肿(SDH):硬脑膜及下方血肿内巨噬细胞反应性的评估
Clin Neuropathol. 2004 Mar-Apr;23(2):62-75.
10
A preliminary study of aquaporin 1 immunolocalization in chronic subdural hematoma membranes.水通道蛋白 1 在慢性硬脑膜下血肿膜中免疫定位的初步研究。
J Clin Neurosci. 2010 Jul;17(7):905-7. doi: 10.1016/j.jocn.2009.11.010. Epub 2010 Apr 20.

引用本文的文献

1
Medical management of chronic subdural hematoma with low-dose hydrocortisone: a case series.小剂量氢化可的松治疗慢性硬脑膜下血肿的医学管理:病例系列。
Neurosurg Rev. 2024 Aug 30;47(1):509. doi: 10.1007/s10143-024-02763-9.
2
Subdural Levels of Interleukin 1-receptor Antagonist are Elevated in Patients with Recurrent Chronic Subdural Hematomas.复发性慢性硬脑膜下血肿患者的白细胞介素 1 受体拮抗剂脑内浓度升高。
Inflammation. 2023 Aug;46(4):1332-1342. doi: 10.1007/s10753-023-01811-8. Epub 2023 Apr 11.
3
Cortical atrophy in chronic subdural hematoma from ultra-structures to physical properties.
慢性硬脑膜下血肿的皮质萎缩:从超微结构到物理特性。
Sci Rep. 2023 Feb 28;13(1):3400. doi: 10.1038/s41598-023-30135-8.
4
Investigation of Neutrophil Extracellular Traps as Potential Mediators in the Pathogenesis of Non-Acute Subdural Hematomas: A Pilot Study.中性粒细胞胞外诱捕网作为非急性硬膜下血肿发病机制中潜在介质的研究:一项初步研究
Diagnostics (Basel). 2022 Nov 24;12(12):2934. doi: 10.3390/diagnostics12122934.
5
Dexamethasone reduces vascular endothelial growth factor in comparison to placebo in post-operative chronic subdural hematoma samples: A target for future drug therapy?与安慰剂相比,地塞米松可降低术后慢性硬膜下血肿样本中的血管内皮生长因子:未来药物治疗的靶点?
Front Neurol. 2022 Sep 8;13:952308. doi: 10.3389/fneur.2022.952308. eCollection 2022.
6
Red Blood Cell Distribution Width to Platelet Count Ratio Facilitates Preoperative Prediction of Recurrence in Surgically Treated Chronic Subdural Hematoma.红细胞分布宽度与血小板计数比值有助于术前预测手术治疗慢性硬膜下血肿的复发情况。
Front Neurol. 2022 May 11;13:884231. doi: 10.3389/fneur.2022.884231. eCollection 2022.
7
The pathophysiology of chronic subdural hematoma revisited: emphasis on aging processes as key factor.慢性硬脑膜下血肿的病理生理学再探讨:强调衰老过程作为关键因素。
Geroscience. 2022 Jun;44(3):1353-1371. doi: 10.1007/s11357-022-00570-y. Epub 2022 Apr 23.
8
Cerebrospinal fluid leak as a driving factor in chronic subdural hematoma formation: A histological study.脑脊液漏作为慢性硬膜下血肿形成的驱动因素:一项组织学研究。
Surg Neurol Int. 2021 Nov 23;12:578. doi: 10.25259/SNI_950_2021. eCollection 2021.
9
Postoperative neutrophil-to-lymphocyte ratio variation is associated with chronic subdural hematoma recurrence.术后中性粒细胞与淋巴细胞比值的变化与慢性硬膜下血肿复发相关。
Neurol Sci. 2022 Jan;43(1):427-434. doi: 10.1007/s10072-021-05241-y. Epub 2021 Apr 23.
10
Impact of inflammatory cell ratio, biomarkers, activated partial thromboplastin time and prothrombin time on chronic subdural haematoma severity and outcome.炎性细胞比值、生物标志物、活化部分凝血活酶时间和凝血酶原时间对慢性硬脑膜下血肿严重程度和结局的影响。
Eur J Trauma Emerg Surg. 2022 Apr;48(2):1085-1092. doi: 10.1007/s00068-021-01665-5. Epub 2021 Apr 11.